FDA Guidance for Industry: Formal Meetings Between the FDA and Sponsors or Applicants of BsUFA Products
Title:
FDA Guidance for Industry: Formal Meetings Between the FDA and
Sponsors or Applicants of BsUFA Products
Origin/Publisher:
FDA, https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM609662.pdf
Content:
This guidance provides recommendations to industry on formal meetings between the Food and Drug Administration (FDA) and sponsors or applicants relating to the development and review of biosimilar or interchangeable biological products regulated by the Center for Drug Evaluation and Research (CDER) or the Center for Biologics Evaluation and Research (CBER).